| 1187 | Frog’s toxin: alkaloid toxins (1); main alkaloid = pumiliotoxin (PTX) (1) | Pumiliotoxin: affects calcium channels (1), increases sodium influx in cerebral synaptoneurosomes (2); cardiotonic, myotonic (2) | (1) Correa et al. (2021); (2) Gusovsky et al. (1988); (3) Loose (2022) | Survival | Mechanism of action: no; toxin name: no; symptoms: yes |
| 1186 | Scopolamine: natural alkaloid of solanaceous plants (1) | Scopolamine: nonselective muscarinic antagonism (2); central sedative, antiemetic, and amnestic effects (2) | (1) Aktories et al. (2013a, p. 132); (2) Renner et al. (2005); (3) Meletzky (2022) | Survival | Mechanism of action: no; symptoms: yes |
| 1174 | NanoBots: production of artificial proteins, nanorobots under development (1) | No mechanism because fictitious | (1) Lehmann (2021); (2) Marka (2021) | Death | Fictitious effect: yes; symptoms: yes |
| 1114 | Phorbol: from spurge family (Euphorbiaceae) (1) | Phorbol: skin irritation (local), toxic, and cocarcinogenic (1); fatal necrotizing/hemorrhagic gastroenteritis, renal injury (1) | (1) Aktories et al. (2013h, p. 1080); (2) Henning (2019) | Death | Mechanism of action: no; symptoms: yes |
| 1107 | Potassium cyanide (KCN): cyanide (2); cannabis: active ingredient tetrahydrocannabinol (1); ecstasy: 3,4-methylenedioxy-methamphetamine (MDMA): abuse popular in the 1980s (3) | KCN: complex formation—> blocking of cytochrome oxidases (2); interruption of the respiratory chain (2); cannabis: analgesic, muscle relaxant, antiemetic (1); MDMA: inhibition of dopamine and norepinephrine reuptake (4) | (1) Hardman et al. (2001d, p. 637); (2) Hardman et el. (2001e, p. 1893); (3) Hardman et al. (2001d, p. 6390; (4) Dekant and Vamvakas (2010a, pp. 236ff); (5) Chahoud (2019) | KCN: death; cannabis: mentioned only in passing; MDMA: mentioned only in passing | Mechanism of action of all three substances: no; symptoms: yes |
| 1096 | Fentanyl patches: Increasing problem: dependence (1); Cannabis: active ingredient tetrahydrocannabinol (2) | Fentanyl patch: full MOR agonist (1); inhibition of excitatory neurotransmitter release (1); cannabis: cannabinoid receptors: analgesic, muscle relaxant, antiemetic (2) | (1) Seifert (2019e, f, pp. 121, 129); (2) Hardman et al. (2001d, p. 637); (3) Kleinert (2019) | Fentanyl patch: death; cannabis: mentioned only in passing | Mechanism of action of both substances: no; symptoms: no |
| 1085 | Dibenzodioxin: most potent representative: 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (1); Yukon powder: fictitious | Dibenzodioxin: tumor-promoting toxic effect through Ah-receptor: regulation protein expression for carcinogenic hydrocarbons (1); Yukon powder: no mechanism because fictitious | (1) Aktories et al. (2013d, g, pp. 1005f, 1055f); (2) Marka (2019) | Dibenzo-dioxin: abortion, maternal survival; Yukon powder: death | Mechanism of action: no; symptoms: yes |
| 1058 | Vacor: rodenticide (1); causes insulin-dependent diabetes mellitus (1) | Vacor: suppression of insulin release independent of cAMP and C-kinase (2) | (1) Esposti et al. (1996); (2) Taniguchi et al. (1989); (3) Dag (2018) | Death | Mechanism of action: no; Symptoms: yes |
| 1051 | Cholinesterase inhibitors: acetylcholinesterase inhibitors (2); glutamate antagonists: NMDAR antagonist (2); antidepressants: treatment of depression (2); citalopram: SSRI (2); antipsychotics: drugs to “eliminate or attenuate psychopathological syndromes and mental illness” (1) | Cholinesterase inhibitors: acetylcholine’s residence time is extended (2); glutamate antagonists: decreased glutamate sensitivity (2); antidepressants: normalize the neurotransmitter deficit (2); citalopram: block serotonin reuptake (2) | (1) Aktories et al. (2013b, p. 294); (2) Seifert (2019b, l, m, pp. 78, 332, 358); (3) Koch (2018) | Survival | Mechanism of action: no; symptoms: yes |
| 1046 | Rabies virus: family: Rhabdoviridae, genus: Lyssavirus (1); turpentine: fluid derived from pine and larch resin (3) | Rabies virus: local replication (2); migration to CNS (2); replication (2); turpentine: contact dermatitis—> irritant effect (4); i.v.: bloody sputum, pneumonia (5); overdose: death (5) | (1) Series editing “RKI-Ratgeber” (2020); (2) Brunker and Mollentze (2018); (3) Bayerische Landesanstalt (2012); (4) Booken et al. (2006); (5) DIE WELT (2012); (6) Zahavi (2018) | Rabies virus: death; turpentine: death | Mechanism of action: no; symptoms: yes |
| 1038 | Substance with no name | No mechanism because no substance is specified | No literature because no substance is specified; (1) Baxmeyer (2017) | Death | Mechanism of action: no; symptoms: no |
| 1037 | Benzene: solvent (4); toluene: solvent (4); radioactive metals: wastes from industry, diagnostics, therapeutics (1); mercury: metallic and organic (1); cyanobacteria/blue-green algae: in fresh and brackish water (2); endo-, cyto-, neuro-, and hepatotoxins (2) | Benzene: damage to the hematopoietic system (4); carcinogenic (4); toluene: “CNS depressant” (4); radioactive metals: radiation emission, chemical toxicity (1); mercury: reaction with free SH groups of proteins (1); cyanobacteria: mechanism still unclear (3) | (1) Aktories et al. (2013e, f, pp. 1023f, 1029); (2) Thebault et al. (1995); (3) van Riel et al. (2007); (4) Hardman et al. (2001e, p. 1893); (5) Bernardi (2017) | Survival | Mechanism of action: yes; symptoms: yes |
| 1018 | Carbon monoxide (CO): gas (1); source: combustion processes (transport, industry, engines) (1) | CO: complex formation with hemoglobin (1); blocks oxygen binding site (1) | (1) Hardman et al. (2001e, pp. 1880ff); (2) Imboden (2017) | Death | Mechanism of action: no; symptoms: no |
| 1012 | Poppy seeds (Papaver somniferum): seeds of the opium poppy (3); few cases of poppy seed allergy known (3) | Poppy seeds: type 1 and type 3 immunological reactions and non-immunological reactions (1); mast cell activation and histamine release (2) | (1) Thiel (1991); (2) Seifert (2019a, p. 52); (3) Senti et al. (2000); (4) Ranisch (2017) | Death | Mechanism of action: no; symptoms: yes |
| 1010 | Ricin: from Ricinus communis (Euphorbiaceae) (1); toxin = lectin (1); in seeds (1); acid-stable (1) | Ricin: blockade of protein biosynthesis (1); necroses of the gastrointestinal tract, liver, kidney, and spleen (1) | (1) Aktories et al. (2013h, pp. 1075f); (2) Marka (2017) | Survival | Mechanism of action: no; symptoms: yes |
| 1009 | Ecstasy: 3,4- methylenedioxy-methamphetamine (MDMA): abuse popular in the 1980s (1); benzodiazepines: frequent clinical application (2); drug group (2); barbiturates: sedatives, hypnotics, and injection narcotics (2); analgesics: drugs for the treatment of pain (2); opioid analgesics and non-opioid analgesics (2) | MDMA: inhibition of dopamine and norepinephrine reuptake (1); benzodiazepines: enhancement of GABAergic inhibition (2); anxiolytic, sedative-hypnotic, muscle relaxant, and antiepileptic (2); barbiturates: enhanced inhibition of excitatory neurotransmission, enhancement of GABAergic inhibitory transmission (2); analgesics: agonism and/or antagonism at pain receptors (2) | (1) Dekant and Vamvakas (2010a, pp. 236ff); (2) Seifert (2019d, j, k, pp. 118ff, 310ff, 328); (3) Spirandelli (2017) | Death | Mechanism of action: no; symptoms: yes |
| 995 | Knockout drops: combination of different substances (1); often sleeping pills or tranquilizers or party drugs (3); abuse for sexual offenses or robberies (1) | Knockout drops: increase acetylcholine, dopamine, and opioid peptides (4); impaired perception, consciousness, or amnesia (2) | (1) FNR-KO-Tropfen-aerzteinformation.pdf (w.d.); (2) Verba (2007); (3) Wikipedia authors (2022); (4) Stein (2003); (5) Zahavi (2016) | Survival | Mechanism of action: no; symptoms: yes |
| 994 | Botulinum toxin: toxin from the bacterium Clostridium botulinum (1); Rabies virus: family: Rhabdoviridae, genus: Lyssavirus (2); exogenous insulins: treatment of type 1 diabetes, later type 2 diabetes (5); increase of diabetic drugs and insulin therapy—an increase of homicides and suicides (6) | Botulinum toxin: inhibition of acetylcholine release at presynaptic cells (1); rabies virus: local replication (3); migration to CNS (3); replication (3); exogenous insulins: Insulin analogs (5); intoxication: hypoglycemia (5); irreparable brain damage, circulatory arrest (4) | (1) Dekant and Vamvakas (2010c, pp. 253f); (2) Series editing “RKI-Ratgeber” (2020); (3) Brunker and Mollentze (2018); (4) Datenblatt: Vergiftung-Antidiabetika (Insulin) (2021); (5) Seifert (2019h, i, pp. 244, 246f); (6) Bottinelli et al. (2020); (7) Jessen (2016) | Survival | Mechanism of action: no; symptoms: yes |
| 956 | Knockout drops: combination of different substances (3); often sleeping pills or tranquilizers or party drugs (5); abuse for sexual offenses or robberies (3); GHB: similar mechanism of action as neurotransmitter GABA (7); “liquid ecstasy” (6); alcohol: ethyl alcohol, ethanol, EtOH (1); narcotic drug (1) | Knockout drops/GHB: increase acetylcholine, dopamine, and opioid peptides (7); impaired perception, consciousness, or amnesia (4); alcohol: neurotoxic, hepato-, pancreatico-, and cardiotoxic (2) | (1) Hardman et al. (2001c, pp. 429ff); (2) Bützer (2016); (3) FNR-KO-Tropfen-Aerzteinformation.pdf (w.d.); (4) Verba (2007); (5) Wikipedia authors (2022); (6) Trendelenburg and Ströhle (2005); (7) Stein (2003); (8) Kren (2015) | Knockout drops/GHB: death and survival; alcohol: survival | Mechanism of action: no; symptoms: yes |
| 917 | Exogenous insulins: treatment of type 1 diabetes, for the advanced type 2 diabetes (2); increase of diabetic drugs and insulin therapy—> increase of homicides and suicides (3); knock-out drops: combination of different substances (5); often sleeping or sedative or party drugs (7); abuse for sexual offenses or robberies (5); GHB: similar mechanism of action as neurotransmitter GABA (9); “liquid ecstasy” (8); amphetamines: synthetic drugs (10); “speed” (10); modafinil: psychostimulant drug (11) propranolol: beta-blocker (12); midazolam: benzodiazepine (2); cytarix: fictitious | Exogenous insulins: Insulin analogs (2); intoxication: hypoglycemia (2); irreparable brain damage, circulatory arrest (1); knockout drops/GHB: increase of acetylcholine, dopamine, and opioid peptides (9); impairment of perception, consciousness or amnesia (6); amphetamines: release of norepinephrine and dopamine (10); centrally stimulating, euphoric (10); modafinil: sympathomimetic (11); inhibition of dopamine reuptake (11); propranolol: inhibition of epinephrine and norepinephrine effects, blocking of ß-receptors (12); midazolam: allosteric GABAA-receptor modulation (2) | (1) Datenblatt: Vergiftung-Antidiabetika (Insulin) (2021); (2) Seifert (2019h, i, j, pp. 244, 246f, 312); (3) Bottinelli et al. (2020); (4) FNR-KO-Tropfen-Aerzteinformation.pdf (w.d.); (5) Verba (2007); (6) Wikipedia authors (2022); (7) Trendelenburg and Ströhle (2005); (8) Stein (2003); (9) Dekant and Vamvakas (2010a, pp. 235f); (10) Walliczek-Dworschak (2019); (11) Hardman et al. (2001a, p. 249); (12) Jauch (2014) | Exogenous insulins: death; knockout drops/GHB: death; amphetamine, modafinil, propranolol, midazolam: mentioned only in passing | Mechanism of action: no; symptoms: yes |
| 905 | Barbiturates: sedatives, hypnotics, and injectable narcotics (1); carbon monoxide (CO): gas (2); source: combustion processes (transport, industry, engines) (2) | Barbiturates: enhanced inhibition of excitatory neurotransmission, enhancement of GABAergic inhibitory transmission (1); CO: forms a complex with hemoglobin (2); blocks oxygen binding site (2) | (1) Seifert (2019j, k, pp. 310, 328); (2) Hardman et al. (2001e, pp. 1880ff); (3) Fischer (2014) | Barbiturates: death; CO: death, survival | Mechanism of action: no; symptoms: yes |
| 765 | Zytrex 3: fictitious | No mechanism because fictitious | No literature because fictitious; (1) Baxmeyer (2010) | Death | Mechanism of action: no; symptoms: yes |
| 750 | Barbiturates: sedatives, hypnotics, and injectable narcotics (1); benzodiazepines: frequently used drug group (1); methaqualone (2-methyl-3-o-tolyl-4 (3H)-quinazolinone): sedative and hypnotic (2); diphenhydramine: first-generation H1 receptor antagonist (1); etodoxizine: fictitious | Barbiturates: enhanced inhibition of excitatory neurotransmission, potentiation of GABAergic inhibitory transmission (1); benzodiazepines: potentiation of GABAergic inhibition (1); anxiolytic, sedative-hypnotic, muscle relaxant, and antiepileptic (1); methaqualone: positive allosteric GABAA receptor modulator (2); diphenhydramine: sedation, antiallergic, itch relief (1) | (1) Seifert (2019c, j, k, pp. 95, 310ff, 328); (2) Ionescu-Pioggia et al. (1988); (3) Moore (2009) | Death | Mechanism of action: no; symptoms: yes |
| 708 | Carbon monoxide (CO): gas (1); source: combustion processes (transport, industry, engines) (1) | CO: forms a complex with hemoglobin (1); blocks oxygen binding site (1) | (1) Hardman et al. (2001e, pp. 1880ff); (2) Pfeiffer (2008) | Death | Mechanism of action: no; symptoms: yes |
| 699 | Barbiturates: sedatives, hypnotics, and injectable narcotics (1); Thelotal: fictitious barbiturate | Barbiturates: enhanced inhibition of excitatory neurotransmission, enhancement of GABAergic inhibitory transmission (1) | (1) Seifert (2019j, k, pp. 310ff, 328); (2) Stelzer (2008) | Death | Mechanism of action: no; Symptoms: no |
| 637 | Aconitine: from Aconitum napellus (aconite) (1); in tuber and seed (2) | Aconitine: direct activation and impairing closing of voltage-gated sodium channels (3) | (1) Dekant and Vamvakas (2010b, pp. 247f); (2) Aktories et al. (2013h, p. 1070); (3) Chan (2009); (4) Garde (2006) | Death | Mechanism of action: no; symptoms: yes |
| 545 | Trimethanoctulol phenyl carbon hydride: fictitious | No mechanism because fictitious | No literature because fictitious; (1) Jauch (2003) | Death | Mechanism of action: no; symptoms: yes |
| 542 | Synthetic poisons: non-natural occurrence, artificial production (1) | No mechanism because no exact substance is mentioned | (1) Auwärter et al. (2012); (2) Emmerich (2003) | Death | Mechanism of action: no; symptoms: yes |
| 505 | Digitalis: family Plantaginaceae (1); active ingredients: digitoxin, digoxin (1); exhaust gases: often carbon monoxide (CO), carbon dioxide (CO2), and/or nitrogen oxides (NOx) (2) | Digitalis: inhibition of Na+/K+-ATPase (3); increase in intracellular calcium concentration (3); positive inotropic and negative dromotropic (3) | (1) Aktories et al. (2013c, p. 414); (2) Ziegler et al. (2014); (3) Seifert (2019g, p. 212); (4) Agthe (2002) | Death | Mechanism of action: no; symptoms: yes |
| 458 | Botulinum toxin: toxin from the bacterium Clostridium botulinum (1) | Botulinum toxin: presynaptic inhibition of acetylcholine release (1) | (1) Dekant and Vamvakas (2010c, pp. 253f); (2) Heidelbach (2000b) | Death | Mechanism of action: no; symptoms: yes |
| 447 | Strychnine: from seeds of Strychnos nux-vomica (poison-nut tree) (1) | Strychnine: blocking of glycine receptors (1) | (1) Hardman et al. (2001e, p. 1894); (2) Fischer (2000) | Death | Mechanism of action: no; symptoms: yes |
| 437 | Potassium cyanide (KCN): cyanide (1) | KCN: complex formation—> blocking of cytochrome oxidases (1); interruption of the respiratory chain (1) | (1) Hardman et al. (2001e, p. 1893); (2) Heidelbach (2000a) | Death | Mechanism of action: yes; symptoms: yes |
| 397 | Carbon monoxide (CO): gas (1); source: combustion processes (transport, industry, engines) (1) | CO: complex formation with hemoglobin (1); blocks oxygen binding site (1) | (1) Hardman et al. (2001e, pp. 1880ff); (2) Freundner (1998) | Death | Mechanism of action: no; symptoms: yes |
| 366 | Cyan nitrate: fictitious | No mechanism because fictitious | No literature because fictitious; (1) Vogel (1997) | Death and survival | Mechanism of action: no; Symptoms: yes |
| 364 | Kilat: fictitious; Pervitin: psychoanaleptic compound (1); similar to ephedrine (1); Valocordin: INN: doxylamine or diazepam (2,3); Tilur: INN: acemetacin (4); COX inhibitor (5) | Pervitin: affects mental and physical behavior (1); Valcordin: doxylamine: first-generation H1 receptor antagonist (6); CNS depressant effect (6); diazepam: anxiolytic, sedative-hypnotic, muscle relaxant, and antiepileptic (7); Tilur: inhibition of prostaglandin formation (5) | (1) Bonhoff (2013); (2) Gmbh (2022); (3) Editorial Gelbe Liste Pharmindex (2022); (4) Gmbh (w.d.); (5) Editorial Gelbe Liste Pharmindex (2016); (6) Kahle (2020); (7) Seifert (2019j, p. 312); (8) Panzer (1997) | Kilat: death; Pervitin, Valcordin, Tilur: mentioned only in passing | Mechanism of action: yes; symptoms: no |
| 342 | Asbestos: fibrous, naturally occurring minerals (2); dibenzodioxin: most potent representative: 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (3) | Asbestos: mechanical irritation, damage to bronchial system and lungs (1); phagocytosis, apoptosis, or necrosis (1); carcinogenic (1); dibenzodioxin: tumor-promoting, toxic effect mediated by Ah receptor: regulation of protein expression for carcinogenic hydrocarbons (3) | (1) Marczynyki et al. (1999); (2) Seidel et al. (2007); (3) Aktories et al. (2013d, g, pp. 1005f, 1055f); (4) Schlotterbeck (1996) | Death and survival | Mechanism of action: no; symptoms: yes |
| 302 | Laposan 31: fictitious | No mechanism because fictitious | No literature because fictitious; (1) Haffter (1995) | Death | Mechanism of action: no; symptoms: yes |
| 278 | Heroin: also called diacetylmorphine (1); rapid development of tolerance (1) | Heroin: strong agonist at opioid receptors (1) | (1) Dekant, Vamvakas (2010a, p. 242); (2) Bannert (1993) | Death and survival | Mechanism of action: no; Symptoms: yes |
| 201 | Knockout drops: combination of different substances (1); often sleeping pills or tranquilizers or party drugs (2); abuse for sexual offenses or robberies (1); heroin: also called diacetylmorphine (4); rapid development of tolerance (4) | Knockout drops: increase in acetylcholine, dopamine, and opioid peptides (5); impairment of perception, consciousness, or amnesia (3); heroin: strong agonist at opioid receptors (4) | (1) FNR-KO-Tropfen-Aerzteinformation.pdf (w.d.); (2) Wikipedia authors (2022); (3) Verba (2007); (4) Dekant and Vamvakas (2010a, p. 242); Stein (2003); (6) Blumenberg (1988) | Knockout drops: death and survival; heroin: death and survival | Mechanism of action: no; symptoms: yes |
| 84 | Exhaust gases: often carbon monoxide (CO), carbon dioxide (CO2) and/or nitrogen oxides (NOx) (1,2); carbon monoxide (CO): gas (1); source: combustion processes (transport, industry, engines) (1) | CO: complex formation with hemoglobin (1); blocks oxygen binding site (1) | (1) Hardman et al. (2001e, pp. 1880ff); (2) Ziegler et al. (2014); (3) Neureuther (1978) | Death | Mechanism of action: no; symptoms: yes |
| 82 | Notin-Gamma-Corbin: fictitious | No mechanism because fictitious | No literature because fictitious; (1) Gies (1977) | Death | Mechanism of action: no; symptoms: yes |
| 76 | Potassium cyanide (KCN): cyanide (1) | KCN: complex formation—> blocking of cytochrome oxidases (1); interruption of the respiratory chain (1) | (1) Hardman et al. (2001e, p. 1893); (2) Gräwert (1977) | Death and survival | Mechanism of action: no; symptoms: no |
| 75 | No substance is mentioned | No mechanism because no substance is mentioned | No literature because no substance is mentioned; (1) Staudte (1977) | Death | Mechanism of action: no; symptoms: yes |
| 50 | Potassium cyanide (KCN): cyanide (1) | KCN: complex formation—> blocking of cytochrome oxidases (1); interruption of the respiratory chain (1) | (1) Hardman et al. (2001e, p. 1893); (2) Wirth (1975) | Death | Mechanism of action: no; symptoms: yes |
| 39 | Carbon monoxide (CO): gas (1); source: combustion processes (transport, industry, engines) (1) | CO: complex formation with hemoglobin (1); blocks oxygen binding site (1) | (1) Hardman et al. (2001e, pp. 1880ff); (2) Becker (1974) | Survival | Mechanism of action: no; symptoms: yes |